Opioid-receptor-heteromer-specific trafficking and pharmacology

Current Opinion in Pharmacology

Volumn 10, Issue 1, 2010, Pages 73-79

  van Rijn, Richard M ^a   Whistler, Jennifer L ^a   Waldhoer, Maria ^b  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 6' GUANIDINONALTRINDOLE; ANALGESIC AGENT; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; ENDORPHIN; G PROTEIN COUPLED RECEPTOR; HETEROMER; KAPPA OPIATE RECEPTOR; LIGAND; MU OPIATE RECEPTOR AGONIST; NALOXONAZINE; NALTRINDOLE; OPIATE; OPIATE RECEPTOR; OXYMORPHONE; POLYMER; UNCLASSIFIED DRUG;

CELL SURFACE; CELLULAR DISTRIBUTION; CONSTIPATION; DRUG DEPENDENCE; DRUG MECHANISM; DRUG TOLERABILITY; DYSPHORIA; ENDOCYTOSIS; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RESPIRATION DEPRESSION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

ALCOHOL DRINKING; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN TRANSPORT; RECEPTORS, OPIOID;

EID: 72449123327     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.09.007     Document Type: Review

References (66)

1. Ling G.S., Simantov R., Clark J.A., and Pasternak G.W. Naloxonazine actions in vivo. Eur J Pharmacol 129 (1986) 33-38
2. Zukin R.S., Eghbali M., Olive D., Unterwald E.M., and Tempel A. Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors. Proc Natl Acad Sci U S A 85 (1988) 4061-4065
3. Zaki P.A., Bilsky E.J., Vanderah T.W., Lai J., Evans C.J., and Porreca F. Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol 36 (1996) 379-401
4. Waldhoer M., Bartlett S.E., and Whistler J.L. Opioid receptors. Annu Rev Biochem 73 (2004) 953-990
5. Pasternak G.W. Multiple opiate receptors: deja vu all over again. Neuropharmacology 47 Suppl 1 (2004) 312-323
6. Ferre S., Baler R., Bouvier M., Caron M.G., Devi L.A., Durroux T., Fuxe K., George S.R., Javitch J.A., Lohse M.J., et al. Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5 (2009) 131-134
7. Levac B.A., O'Dowd B.F., and George S.R. Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol 2 (2002) 76-81
8. Cvejic S., and Devi L.A. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272 (1997) 26959-26964
9. Gainetdinov R.R., Premont R.T., Bohn L.M., Lefkowitz R.J., and Caron M.G. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27 (2004) 107-144
10. Martini L., and Whistler J.L. The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 17 (2007) 556-564
11. Whistler J.L., Enquist J., Marley A., Fong J., Gladher F., Tsuruda P., Murray S.R., and Von Zastrow M. Modulation of postendocytic sorting of G protein-coupled receptors. Science 297 (2002) 615-620
12. Williams J.T., Christie M.J., and Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81 (2001) 299-343
13. Kim J.A., Bartlett S., He L., Nielsen C.K., Chang A.M., Kharazia V., Waldhoer M., Ou C.J., Taylor S., Ferwerda M., et al. Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol 18 (2008) 129-135. Using a knock-in mouse model the authors provide in vivo evidence to support the hypothesis that the inability of MOP-Rs to endocytose after morphine activation lies at the base of the establishment of morphine tolerance.
14. Zollner C., Mousa S.A., Fischer O., Rittner H.L., Shaqura M., Brack A., Shakibaei M., Binder W., Urban F., Stein C., et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 118 (2008) 1065-1073. This study shows that, in a clinically relevant model of inflammatory pain, the presence of endogenous opioids prevents the establishment of peripheral morphine tolerance.
15. He L., Fong J., von Zastrow M., and Whistler J.L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108 (2002) 271-282
16. He L., and Whistler J.L. An opiate cocktail that reduces morphine tolerance and dependence. Curr Biol 15 (2005) 1028-1033. This study describes the development of a morphine-methadone cocktail that drives MOP-R homomer endocytosis. Shows that promoting endocytosis reduces tolerance and dependence.
17. Bie B., and Pan Z.Z. Trafficking of central opioid receptors and descending pain inhibition. Mol Pain 3 (2007) 37. A review of the mechanism and different conditions under which DOP-Rs redistribute from large dense core vesicles to the cell surface.
18. Margolis E.B., Fields H.L., Hjelmstad G.O., and Mitchell J.M. Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28 (2008) 12672-12681
19. Guan J.-S., Xu Z.-Z., Gao H., He S.-Q., Ma G.-Q., Sun T., Wang L.-H., Zhang Z.-N., Lena I., and Kitchen I. Interaction with vesicle luminal protachykinin regulates surface expression of d-opioid receptors and opioid analgesia. Cell 122 (2005) 619-631
20. Cahill C.M., Morinville A., Lee M.C., Vincent J.P., Collier B., and Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21 (2001) 7598-7607
21. Morinville A., Cahill C.M., Esdaile M.J., Aibak H., Collier B., Kieffer B.L., and Beaudet A. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23 (2003) 4888-4898
22. Scherrer G., Imamachi N., Cao Y.Q., Contet C., Mennicken F., O'Donnell D., Kieffer B.L., and Basbaum A.I. Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137 (2009) 1148-1159. Elaborate study showing that spinal MOP-R and DOP-R each have a distinct location and a distinct function in the spinal cord.
23. Gomes I., Filipovska J., Jordan B., and Devi L. Oligomerization of opioid receptors. Methods 27 (2002) 358
24. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., and O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275 (2000) 26128-26135
25. Gomes I., Gupta A., Filipovska J., Szeto H.H., Pintar J.E., and Devi L.A. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101 (2004) 5135-5139
26. Law P.Y., Erickson-Herbrandson L.J., Zha Q.Q., Solberg J., Chu J., Sarre A., and Loh H.H. Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280 (2005) 11152-11164
27. Wang D., Sun X., Bohn L.M., and Sadee W. Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol Pharmacol 67 (2005) 2173-2184
28. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
29. Pan Y., Bolan E., and Pasternak G. Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype. Biochem Biophys Res Commun 297 (2002) 659
30. Bhushan R.G., Sharma S.K., Xie Z., Daniels D.J., and Portoghese P.S. A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J Med Chem 47 (2004) 2969-2972
31. Portoghese P.S., and Lunzer M.M. Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord. Eur J Pharmacol 467 (2003) 233-234
32. Porreca F., Takemori A.E., Sultana M., Portoghese P.S., Bowen W.D., and Mosberg H.I. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 263 (1992) 147-152
33. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20 (2000) RC110
34. Van Rijn R.M., and Whistler J.L. The delta-1 opioid receptor is a heterodimer that opposes the actions of the delta-2 receptor on alcohol intake. Biol Psychiatry 66 (2009) 777-784. This study shows that DOP-R1 and DOP-R2s have opposing effects on alcohol consumption and represent distinct pharmacological targets that can work synergistically. Also shows that the effects of DOP-R1 require both DOP-R and MOP-R, suggesting that DOP-R1 could be a DOP/MOP-R heteromer.
35. Hosohata Y., Vanderah T.W., Burkey T.H., Ossipov M.H., Kovelowski C.J., Sora I., Uhl G.R., Zhang X., Rice K.C., Roeske W.R., et al. delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice. Eur J Pharmacol 388 (2000) 241-248
36. Clark J.A., Liu L., Price M., Hersh B., Edelson M., and Pasternak G.W. Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype. J Pharmacol Exp Ther 251 (1989) 461-468
37. Wolozin B.L., and Pasternak G.W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc Natl Acad Sci U S A 78 (1981) 6181-6185
38. Pfeiffer M., Kirscht S., Stumm R., Koch T., Wu D., Laugsch M., Schroder H., Hollt V., and Schulz S. Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278 (2003) 51630-51637
39. Chen C., Li J., Bot G., Szabo I., Rogers T.J., and Liu-Chen L.Y. Heterodimerization and cross-desensitization between the micro-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483 (2004) 175-186
40. Jordan B.A., Gomes I., Rios C., Filipovska J., and Devi L.A. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 64 (2003) 1317-1324
41. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., and Devi L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 98 (2001) 343-348
42. Decaillot F.M., Rozenfeld R., Gupta A., and Devi L.A. Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A 105 (2008) 16045-16050. This work shows that members of the receptor transporter protein family may act as chaperones to assist cell surface targeting of DOP/MOP-R heteromers.
43. Waldhoer M., Fong J., Jones R.M., Lunzer M.M., Sharma S.K., Kostenis E., Portoghese P.S., and Whistler J.L. A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers. Proc Natl Acad Sci U S A 102 (2005) 9050-9055. This work describes a ligand with novel properties on a DOP/KOP-R heteromer, distinct from those at the homomeric receptors. Demonstrates that this ligand is a tissue-selective analgesic.
44. Hasbi A., Nguyen T., Fan T., Cheng R., Rashid A., Alijaniaram M., Rasenick M.M., O'Dowd B.F., and George S.R. Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry 46 (2007) 12997-13009. An elegant study showing how DOP/MOP-R heteromers are formed only in the ER, and not after translocation to the cell surface.
45. Van Rijn R.M., and Whistler J.L. The only way is up: preventing opioid tolerance by promoting cell surface expression of MOR-DOR heterodimers?. Mol Interv 8 (2008) 277-280
46. Koch T., Widera A., Bartzsch K., Schulz S., Brandenburg L.O., Wundrack N., Beyer A., Grecksch G., and Hollt V. Receptor endocytosis counteracts the development of opioid tolerance. Mol Pharmacol 67 (2005) 280-287
47. Qiu Y., Loh H.H., and Law P.Y. Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. J Biol Chem 282 (2007) 22315-22323
48. Chu P., Murray S., Lissin D., and von Zastrow M. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272 (1997) 27124-27130
49. Murtra P., Sheasby A.M., Hunt S.P., and De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 405 (2000) 180-183
50. Gu G., Kondo I., Hua X.Y., and Yaksh T.L. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence. J Pharmacol Exp Ther 314 (2005) 1362-1369
51. Zheng H., Chu J., Qiu Y., Loh H.H., and Law P.Y. Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A 105 (2008) 9421-9426
52. Portoghese P.S. From models to molecules: opioid receptor dimers, bivalent ligands, and selective opioid receptor probes. J Med Chem 44 (2001) 2259-2269
53. Daniels D.J., Kulkarni A., Xie Z., Bhushan R.G., and Portoghese P.S. A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes. J Med Chem 48 (2005) 1713-1716
54. Daniels D.J., Lenard N.R., Etienne C.L., Law P.Y., Roerig S.C., and Portoghese P.S. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. Proc Natl Acad Sci U S A 102 (2005) 19208-19213
55. Peng X., Knapp B.I., Bidlack J.M., and Neumeyer J.L. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors. J Med Chem 50 (2007) 2254-2258
56. Abdelhamid E.E., Sultana M., Portoghese P.S., and Takemori A.E. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther 258 (1991) 299-303
57. Neumeyer J.L., Zhang A., Xiong W., Gu X.H., Hilbert J.E., Knapp B.I., Negus S.S., Mello N.K., and Bidlack J.M. Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors. J Med Chem 46 (2003) 5162-5170
58. Peng X., Knapp B.I., Bidlack J.M., and Neumeyer J.L. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors. J Med Chem 49 (2006) 256-262
59. Neumeyer J.L., Peng X., Knapp B.I., Bidlack J.M., Lazarus L.H., Salvadori S., Trapella C., and Balboni G. New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores. J Med Chem 49 (2006) 5640-5643
60. Mathews J.L., Fulton B.S., Negus S.S., Neumeyer J.L., and Bidlack J.M. In vivo characterization of (-)(-)MCL-144 and (+)(-)MCL-193: isomeric, bivalent ligands with mu/kappa agonist properties. Neurochem Res 33 (2008) 2142-2150
61. Gear R.W., Miaskowski C., Gordon N.C., Paul S.M., Heller P.H., and Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med 2 (1996) 1248-1250
62. 2A are endocytosed when coactivated by serotonin and morphine, but not by either drug alone.
63. Kuszak A.J., Pitchiaya S., Anand J.P., Mosberg H.I., Walter N.G., and Sunahara R.K. Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem 284 (2009) 26732-26741. Using reconstituted MOP-R and single molecule imaging, the authors show that MOP-R monomers are the minimal functional unit for receptor activation.
64. Terpager M., Scholl D.J., Kubale V., Martini L., Elling E.C., and Schwartz T.W. Construction of covalently coupled, concatameric dimers of 7TM receptors. J Receptors Signal Trans 29 (2009) 235-245
65. Filizola M., and Weinstein H. Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. Biopolymers 66 (2002) 317-325
66. Filizola M., and Weinstein H. The study of G-protein-coupled receptor oligomerization with computational modeling and bioinformatics. FEBS J 272 (2005) 2926-2938